Conclusion:
COVID 19 pandemic has resulted in many burdens on the social, financial,
psychological, and physical aspects. COVID 19 vaccines were recently
introduced to help combat the effects of this pandemic. These vaccines
are effective with great immunogenicity; however, their complete safety
is not yet established. Therefore, the potential benefits of the
vaccines are outweighed by the potential benefits, and more studies are
needed to further unveil all the potential risks from these vaccines. MS
risk of Relapse decreases with age and those with stable disease.
However, the development of MS relapse following the vaccine
administration should be considered a potential side effect.
Data availability
statement:The data that support the findings of this study are available from the
corresponding author upon reasonable request.
Conflict of interest: The authors have no conflict of interest to declare.